Sort
21,281 grants matching “influenza”
Solitary chemosensory / tuft cells in lung regeneration and inflammation
$398,180Andrew Vaughan · University Of Pennsylvania · R01 · FY2020 · HL
Innovative Interdisciplinary Approaches to Sustainable Airborne Infection Control
$398,166Edward A. Nardell · Brigham And Women'S Hospital · D43 · FY2015 · TW
Understanding fusion peptide mutations in influenza hemagglutinin
$398,050Peter M Kasson · University Of Virginia · R01 · FY2015 · GM
Influenza Typing Using a New Real-Time DNA Amplification on a Portable Electronic
$398,037Dalibor Hodko · Nexogen, Inc. · R44 · FY2010 · AI
Lung resident niches for memory CD4 T cells
$398,013Donna L Farber · Columbia University Health Sciences · R01 · FY2018 · HL
Lung resident niches for memory CD4 T cells
$398,013Donna L Farber · Columbia University Health Sciences · R01 · FY2015 · HL
Lung resident niches for memory CD4 T cells
$398,013Donna L Farber · Columbia University Health Sciences · R01 · FY2016 · HL
Lung resident niches for memory CD4 T cells
$398,013Donna L Farber · Columbia University Health Sciences · R01 · FY2017 · HL
Targeting M. catarrhalis for Prevention and Treatment of Otitis Media
$397,961Anthony A Campagnari · State University Of New York At Buffalo · R01 · FY2019 · DC
Targeting M. catarrhalis for Prevention and Treatment of Otitis Media
$397,961Anthony A Campagnari · State University Of New York At Buffalo · R01 · FY2020 · DC
Targeting M. catarrhalis for Prevention and Treatment of Otitis Media
$397,961Anthony A Campagnari · State University Of New York At Buffalo · R01 · FY2017 · DC
Targeting M. catarrhalis for Prevention and Treatment of Otitis Media
$397,961Anthony A Campagnari · State University Of New York At Buffalo · R01 · FY2018 · DC
Elucidation of Antisickling Molecules in a Botanical with Antisickling Activity
$397,926Robert Swift · Invenux, Llc · R41 · FY2013 · AT
TREAT ECARDS: Translating Evidence into Action: Electronic Clinical Decision Support in ARDS
$397,898Michelle Ng Gong · Albert Einstein College Of Medicine · R18 · FY2019 · HS
TREAT ECARDS: Translating Evidence into Action: Electronic Clinical Decision Support in ARDS
$397,809Michelle Ng Gong · Albert Einstein College Of Medicine · R18 · FY2020 · HS
Analysis of Respiratory Syncytial Virus Gene Products
$397,803Gail Wiliams Wertz · University Of Virginia · R01 · FY2008 · AI
Fidelity, robustness, and diversity in RNA virus evolution and pathogenesis
$397,708Adam Lauring · University Of Michigan At Ann Arbor · R01 · FY2016 · AI
Plasma Gelsolin and Host Defense After Lung Injury
$397,693Lester Kobzik · Harvard School Of Public Health · R01 · FY2015 · HL
Drug Discovery Targeting the Influenza A Virus M2-S31N Proton Channel
$397,672Jun Wang · University Of Arizona · R33 · FY2017 · AI
System Immunogenetics of West Nile Virus Infection Adaptive Immunity
$397,595Jennifer M Lund · Univ Of North Carolina Chapel Hill · U19 · FY2015 · AI
Impact of aging on the T cell repertoire and cellular immunity to influenza virus
$397,518Marcia A Blackman · Trudeau Institute, Inc. · P01 · FY2012 · AG
Endothelial antigen presentation to T cells as a pathogenic mechanism in influenza-induced acute lung injury
$397,500Lianghui Zhang · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · HL
Metabolic alterations in age-associated dendritic cell dysfunction
$397,500Edith M Janssen · Cincinnati Childrens Hosp Med Ctr · R01 · FY2018 · AG
Endothelial antigen presentation to T cells as a pathogenic mechanism in influenza-induced acute lung injury
$397,500Lianghui Zhang · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · HL
Role of type III interferons in Staphylococcus aureus respiratory tract infection
$397,500Dane Parker · Rbhs-New Jersey Medical School · R01 · FY2018 · HL